Lloyds Banking Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-3,879
Closed -$378K 417
2014
Q3
$378K Sell
3,879
-1,012
-21% -$99.5K 0.1% 207
2014
Q2
$493K Sell
4,891
-51,715
-91% -$5.05M 0.12% 188
2014
Q1
$5.2M Sell
56,606
-2,571
-4% -$237K 0.05% 304
2013
Q4
$5.35M Buy
59,177
+5,997
+11% +$519K 0.05% 289
2013
Q3
$4.24M Buy
53,180
+1,304
+3% +$103K 0.04% 296
2013
Q2
$3.77M Buy
+51,876
New +$3.88M 0.04% 300

Other funds holding ZBH

Lloyds Banking Group's ZBH Position: Q4 2014 in Review

Lloyds Banking Group sold out of Zimmer Biomet (ZBH) in Q4 2014, closing a stake of 3,879 shares — an estimated $378K sold.

Lloyds Banking Group first reported a position in ZBH in Q2 2013 and held it in 6 quarters. The position peaked at $5.35M in Q4 2013. 750 funds tracked by Wall St. Rank hold ZBH as of Q4 2014.

  • Lloyds Banking Group reported no remaining Zimmer Biomet position as of Q4 2014 after selling out during the quarter.
  • Lloyds Banking Group sold 3,879 Zimmer Biomet shares in Q4 2014, an estimated $378K.
  • Lloyds Banking Group first reported a position in Zimmer Biomet in Q2 2013 and held it in 6 quarters.
  • Lloyds Banking Group's Zimmer Biomet position peaked at $5.35M in Q4 2013.
  • 750 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2014.

Based on Lloyds Banking Group's 13F filing for Q4 2014, filed 12 Feb 2015.